2020
DOI: 10.3390/ijms21041206
|View full text |Cite
|
Sign up to set email alerts
|

In Steatotic Cells, ATP-Citrate Lyase mRNA Is Efficiently Translated through a Cap-Independent Mechanism, Contributing to the Stimulation of De Novo Lipogenesis

Abstract: Non-alcoholic fatty liver disease (NAFLD) is a chronic disease in which excessive amount of lipids is accumulated as droplets in hepatocytes. Recently, cumulative evidences suggested that a sustained de novo lipogenesis can play an important role in NAFLD. Dysregulated expression of lipogenic genes, including ATP-citrate lyase (ACLY), has been found in liver diseases associated with lipid accumulation. ACLY is a ubiquitous cytosolic enzyme positioned at the intersection of nutrients catabolism and cholesterol … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 49 publications
1
6
0
Order By: Relevance
“…NAFLD patients are characterized by an increased load of free fatty acids (FFAs) in the liver, which can be due both to increased lipolysis from adipose tissue but also to de novo lipogenesis in hepatocytes [24][25][26][27][28][29][30]. Insulin resistance has a prominent role in these processes by favoring an increased lipolytic response to the meal, and by inducing the expression of lipogenic pathways in the liver [24,25,27,31,32]. In the liver, FFAs are metabolized by beta-oxidation in mitochondria, or esterified as triglycerides (TGs), and either secreted within very-low-density lipoproteins (VLDL) or stored in lipid droplets leading to hepatic steatosis [25].…”
Section: Lipotoxicity In Hepatocytesmentioning
confidence: 99%
“…NAFLD patients are characterized by an increased load of free fatty acids (FFAs) in the liver, which can be due both to increased lipolysis from adipose tissue but also to de novo lipogenesis in hepatocytes [24][25][26][27][28][29][30]. Insulin resistance has a prominent role in these processes by favoring an increased lipolytic response to the meal, and by inducing the expression of lipogenic pathways in the liver [24,25,27,31,32]. In the liver, FFAs are metabolized by beta-oxidation in mitochondria, or esterified as triglycerides (TGs), and either secreted within very-low-density lipoproteins (VLDL) or stored in lipid droplets leading to hepatic steatosis [25].…”
Section: Lipotoxicity In Hepatocytesmentioning
confidence: 99%
“…Insulin resistance is known to lead to an abnormal response in liver wherein elevated blood insulin levels don't efficiently reduce gluconeogenesis but instead activates hepatic De Novo Lipogenesis. In insulin resistant liver, activated De Novo Lipogenesis together with increased influx of fatty acids from adipose tissue lipolysis leads to triglycerides and lipotoxic metabolites accumulation ( Siculella et al., 2020 ). Long term dietary cholesterol is known to cause profound liver damage, evident by significant accumulation of both hepatic TG and cholesterol, marked decrease in liver density, accompanied by increased plasma levels of ALT and AST, indicating impaired liver function ( Jensen et al., 2018 ).…”
Section: Discussionmentioning
confidence: 99%
“…RNA extraction and reverse transcription were carried out as previously reported [ 36 ]. Quantitative gene expression analysis was carried out on CFX Connect™ Real-Time PCR Detection System (Bio-Rad Laboratories, Segrate, Italy), using SYBR ® Select Master Mix for CFX (Life Technologies) and 18S rRNA for normalization [ 37 ]. The primers used for real-time PCR analysis were as follows hRIDAfor (5′-GGAGGGGTAGCAGAAGAAG-3′); hRIDArev (5′-TGAAGTCATTTATGTCAGCCAG-3′); hSIRT5for (5′-GTCCACACGAAACCAGATTTGCC-3′); hSIRT5rev (5′-TCCTCTGAAGGTCGGAACACCA-3′).…”
Section: Methodsmentioning
confidence: 99%